LAS VEGAS, Feb. 26 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today it has named Shamoon Ahmad, M.D., M.B.A., FACP as Medical Director and Leader of its Medical Advisory Board.
Dr. Ahmad is currently Director of the Cancer Therapy & Integrative Medicine Institute in Las Vegas, Nevada. He also serves as President of the Nevada Oncology Society and is an Associate Professor at the Touro University School of Medicine in Las Vegas.
"Our Medical Board serves to ensure the quality of our program and guides the Company on medical issues, compliance and training. We are delighted to have such an experienced, talented physician as Dr. Ahmad overseeing our efforts," said Matthew Schissler, co-founder and CEO.
Dr. Ahmad completed his fellowship in hematology, medical oncology and bone marrow transplantation at Mount Sinai School of Medicine in New York. His Residency in Internal Medicine was completed at Seton Hall University. His Graduate Education was completed at Dow Medical College in Pakistan. He has received America's Best Physicians recognition and has played a vital role in an ongoing effort to improve both Medicare and the malpractice system in Nevada.
About Cord Blood America
Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
Cord Blood America, Inc.
CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.
Web Site: http://www.cordblood-america.com/
http://www.corcell.com/
